Tegaserod -- a selective 5-HT 4 partial agonist -- recently was approved in the U.S. for treating the constipated variant of irritable bowel syndrome (IBS). However, the safety of IBS treatments ...

Preparation of suspensions of tegaserod began with thorough crushing of tegaserod maleate tablets containing 6 mg of the drug base a in an aluminum foil pouch with the back of a metal teaspoon.